0001209191-21-059676.txt : 20211005 0001209191-21-059676.hdr.sgml : 20211005 20211005190455 ACCESSION NUMBER: 0001209191-21-059676 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211005 DATE AS OF CHANGE: 20211005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novack David F CENTRAL INDEX KEY: 0001573072 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 211308246 MAIL ADDRESS: STREET 1: 39 YORKSHIRE DR CITY: OAKLAND STATE: CA ZIP: 94618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 900 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 900 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-01 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001573072 Novack David F C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 900 EMERYVILLE CA 94608 0 1 0 0 President & COO Common Stock 2021-10-01 4 S 0 17000 18.2261 D 67066 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021. This transaction was executed in multiple trades at prices ranging from $17.04 to $18.50; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax. /s/ David Novack 2021-10-05